Search results
Showing 1 to 3 of 3 results for ta455
Evidence-based recommendations on adalimumab (Humira), etanercept (Enbrel) and ustekinumab (Stelara) for plaque psoriasis in children and young people.
Recommendation ID TA455/1 Question Trials that evaluate utility values (using generic preference-based measures) in children and young
TA455/1 | Trials that evaluate utility values (using generic preference-based measures)